| PERIOD ENDING | 29-Nov-09 | 30-Aug-09 | 31-May-09 | 22-Feb-09 | | Total Revenue | 4,078,200 | 3,518,800 | 3,645,700 | 3,537,400 | | Cost of Revenue | 2,332,100 | 2,060,100 | 2,101,100 | 2,259,900 | | | Gross Profit | 1,746,100 | 1,458,700 | 1,544,600 | 1,277,500 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 842,500 | 766,600 | 834,100 | 671,000 | | Non Recurring | 24,900 | (800) | 79,100 | 1,200 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 878,700 | 692,900 | 631,400 | 605,300 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,300) | 2,300 | (11,500) | 700 | | Earnings Before Interest And Taxes | 696,000 | 695,200 | 619,900 | 606,000 | | Interest Expense | (94,200) | 94,200 | 90,900 | 101,100 | | Income Before Tax | 790,200 | 601,000 | 529,000 | 504,900 | | Income Tax Expense | 261,600 | 203,200 | 182,400 | 231,700 | | Minority Interest | (1,300) | (1,400) |
-
|
-
| | | | Net Income From Continuing Ops | 565,500 | 420,600 | 358,800 | 288,900 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 565,500 | 420,600 | 358,800 | 288,900 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $565,500 | $420,600 | $358,800 | $288,900 |
|
0.60% Nasdaq 
Income Statement
